Preclinical progression of new organic compounds with targeted biological activity (Q19981): Difference between revisions
Jump to navigation
Jump to search
(Removed claim: financed by (P890): Directorate-General for Regional and Urban Policy (Q8361), Removing unnecessary financed by statement) |
(Changed an Item: Change because item Q214251 was merged with Q4868) |
||
| Property / contained in NUTS | Property / contained in NUTS | ||
Revision as of 19:52, 27 December 2020
Project Q19981 in Czech Republic
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Preclinical progression of new organic compounds with targeted biological activity |
Project Q19981 in Czech Republic |
Statements
92,429,398.75 Czech koruna
0 references
108,740,469.26 Czech koruna
0 references
85.0 percent
0 references
1 August 2018
0 references
31 December 2022
0 references
Masarykova univerzita
0 references
49°12'8.64"N, 16°36'28.44"E
0 references
49°11'55.68"N, 16°36'7.06"E
0 references
60200
0 references
Cílem projektu je optimalizace a preklinická profilace vybraných sloučenin s unikátní biologickou aktivitou s potenciálem vykázat terapeutickou účinnost při minimálních nežádoucích vedlejších účincích v oblasti onkologie a kardiologie. Náplní projektu bude mj. příprava širokého setu sloučenin a důkladné testování biologických a obzvláště farmakologických vlastností, včetně in vivo studií. Vzniklé duševní vlastnictví bude důsledně ošetřeno. Výsledky (TRL3)budou dopracovány s aplikačními firmami. a. (Czech)
0 references
The aim of the project is to optimise and preclinical profiling of selected compounds with unique biological activity with the potential to demonstrate therapeutic efficacy in minimal undesirable side effects in the field of oncology and cardiology. The project will include the preparation of a wide set of compounds and thorough testing of biological and especially pharmacological properties, including in vivo studies. The intellectual property generated will be treated consistently. Results (TRL3) will be completed with application companies. a. (English)
22 October 2020
0 references
Identifiers
CZ.02.1.01/0.0/0.0/16_025/0007381
0 references